Skip to main content
Erschienen in: International Journal of Clinical Oncology 2/2015

01.04.2015 | Original Article

Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma

verfasst von: Shigeru Sakano, Hideyasu Matsuyama, Yoriaki Kamiryo, Shigeaki Hayashida, Norio Yamamoto, Yoshitaka Kaneda, Takahito Nasu, Yoshikazu Baba, Tomoyuki Shimabukuro, Akinobu Suga, Mitsutaka Yamamoto, Akihiko Aoki, Kimio Takai, Satoru Yoshihiro, Kazuo Oba, The Yamaguchi Uro-Oncology Group

Erschienen in: International Journal of Clinical Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with urinary bladder urothelial carcinoma (UC) with variant histology have features of more advanced disease and a likelihood of poorer survival than those with pure UC. We investigated the impact of variant histology on disease aggressiveness and clinical outcome after radical nephroureterectomy (RNU) in Japanese patients with upper tract UC (UTUC). Information on variant histology might guide appropriate patient selection for adjuvant therapy after RNU.

Methods

We enrolled 502 UTUC patients treated with RNU in this retrospective cohort study, and analyzed associations of variant histology with clinicopathological variables and disease-specific survival.

Results

The median follow-up was 41.4 months. A total of 60 (12.0 %) UTUC patients had variant histology. UTUC with variant histology was significantly associated with advanced pathological T stage (pT ≥ 3), higher tumor grade (G3), and more lymphovascular invasion (P < 0.0001). Variant histology in all patients was significantly associated with worse disease-specific survival after RNU on univariate analysis (P = 0.0004), but this effect did not remain significant on multivariate analysis. However, variant histology was a significantly independent predictor for disease-specific survival in patients with pT ≥ 3 tumors (P = 0.0095).

Conclusions

UTUC with variant histology might be a phenotype of high-grade, locally aggressive advanced tumors rather than of systemic disease. Variant histology may be useful for selection of patients with pT ≥ 3 UTUC for adjuvant therapy. Prospective studies in a larger number of patients with a centralized pathological review are needed to confirm our results.
Literatur
1.
Zurück zum Zitat Roupret M, Zigeuner R, Palou J et al (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584–594CrossRefPubMed Roupret M, Zigeuner R, Palou J et al (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59:584–594CrossRefPubMed
2.
Zurück zum Zitat Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53:720–731CrossRefPubMed Zigeuner R, Pummer K (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53:720–731CrossRefPubMed
3.
Zurück zum Zitat Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115:1224–1233CrossRefPubMed Margulis V, Shariat SF, Matin SF et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115:1224–1233CrossRefPubMed
4.
Zurück zum Zitat Sakano S, Matsuyama H, Kamiryo Y et al (2013) Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Ann Surg Oncol 20:4389–4396CrossRefPubMed Sakano S, Matsuyama H, Kamiryo Y et al (2013) Risk group stratification based on preoperative factors to predict survival after nephroureterectomy in patients with upper urinary tract urothelial carcinoma. Ann Surg Oncol 20:4389–4396CrossRefPubMed
5.
Zurück zum Zitat Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27:612–618CrossRefPubMedCentralPubMed Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27:612–618CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Black PC, Brown GA, Dinney CP (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27:3–7CrossRefPubMed Black PC, Brown GA, Dinney CP (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27:3–7CrossRefPubMed
7.
Zurück zum Zitat Pons F, Orsola A, Morote J et al (2011) Variant forms of bladder cancer: basic considerations on treatment approaches. Curr Oncol Rep 13:216–221CrossRefPubMed Pons F, Orsola A, Morote J et al (2011) Variant forms of bladder cancer: basic considerations on treatment approaches. Curr Oncol Rep 13:216–221CrossRefPubMed
8.
Zurück zum Zitat Honma I, Masumori N, Sato E et al (2004) Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology 64:744–748CrossRefPubMed Honma I, Masumori N, Sato E et al (2004) Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology 64:744–748CrossRefPubMed
9.
Zurück zum Zitat Perez-Montiel D, Wakely PE, Hes O et al (2006) High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 19:494–503CrossRefPubMed Perez-Montiel D, Wakely PE, Hes O et al (2006) High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol 19:494–503CrossRefPubMed
10.
Zurück zum Zitat Holmang S, Lele SM, Johansson SL (2007) Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol 178:51–56CrossRefPubMed Holmang S, Lele SM, Johansson SL (2007) Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol 178:51–56CrossRefPubMed
11.
Zurück zum Zitat Rink M, Robinson BD, Green DA et al (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188:398–404CrossRefPubMed Rink M, Robinson BD, Green DA et al (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188:398–404CrossRefPubMed
12.
Zurück zum Zitat Matsumoto K, Novara G, Gupta A et al (2011) Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 108:E304–E309CrossRefPubMed Matsumoto K, Novara G, Gupta A et al (2011) Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int 108:E304–E309CrossRefPubMed
13.
Zurück zum Zitat Mostofi FK, Sorbin LH, Torloni H (1973) Histological typing of urinary bladder tumours. International classification of tumours, vol 19. World Health Organization, Geneva Mostofi FK, Sorbin LH, Torloni H (1973) Histological typing of urinary bladder tumours. International classification of tumours, vol 19. World Health Organization, Geneva
14.
Zurück zum Zitat Akao J, Matsuyama H, Yamamoto Y et al (2008) Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer. BJU Int 102:572–575CrossRefPubMed Akao J, Matsuyama H, Yamamoto Y et al (2008) Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer. BJU Int 102:572–575CrossRefPubMed
15.
Zurück zum Zitat Kim SP, Frank I, Cheville JC et al (2012) The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol 188:405–409CrossRefPubMed Kim SP, Frank I, Cheville JC et al (2012) The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol 188:405–409CrossRefPubMed
16.
Zurück zum Zitat Jenkins P, Anjarwalla S, Gilbert H et al (2009) Defining the clinical target volume for bladder cancer radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 75:1379–1384CrossRefPubMed Jenkins P, Anjarwalla S, Gilbert H et al (2009) Defining the clinical target volume for bladder cancer radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 75:1379–1384CrossRefPubMed
17.
Zurück zum Zitat Czito B, Zietman A, Kaufman D et al (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172:1271–1275CrossRefPubMed Czito B, Zietman A, Kaufman D et al (2004) Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol 172:1271–1275CrossRefPubMed
18.
Zurück zum Zitat Chromecki TF, Cha EK, Fajkovic H et al (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61:245–253CrossRefPubMed Chromecki TF, Cha EK, Fajkovic H et al (2012) The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61:245–253CrossRefPubMed
Metadaten
Titel
Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma
verfasst von
Shigeru Sakano
Hideyasu Matsuyama
Yoriaki Kamiryo
Shigeaki Hayashida
Norio Yamamoto
Yoshitaka Kaneda
Takahito Nasu
Yoshikazu Baba
Tomoyuki Shimabukuro
Akinobu Suga
Mitsutaka Yamamoto
Akihiko Aoki
Kimio Takai
Satoru Yoshihiro
Kazuo Oba
The Yamaguchi Uro-Oncology Group
Publikationsdatum
01.04.2015
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 2/2015
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-014-0721-3

Weitere Artikel der Ausgabe 2/2015

International Journal of Clinical Oncology 2/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.